Prime.io's genome editing tools, reagents and services — including bespoke knock-in and knock-out cell line generation, custom sgRNAs, donor templates and pooled screening libraries — become available

​

Sir Tony Kouzarides, Co-founder of Milner Therapeutics Institute and Abcam plc, and Venture Partner at Fifty Years, is appointed as Scientific Advisor.